A research team at Washington University in St. Louis tested a psychedelic that acts on serotonin. Serotonin helps control the widening and narrowing of blood vessels, so the team wanted to see if blood-flow signals still match neural activity.
In mice given the drug, blood flow did not change in the usual way when neurons were active. A second medication that blocks a specific serotonin receptor removed those unusual blood-flow effects. The researchers then used psilocybin in more mouse experiments and reanalyzed human fMRI data; both showed comparable changes. The finding means blood flow–based scans may not always show true neural activity after psychedelics.
Difficult words
- psychedelic — a drug that changes perception and thinking
- serotonin — a chemical in the body that affects blood vessels
- receptor — a protein on cells that receives signals
- psilocybin — a psychedelic compound found in some mushrooms
- blood flow — movement of blood through body vesselsblood-flow
- neural — related to nerves or brain cells
Tip: hover, focus or tap highlighted words in the article to see quick definitions while you read or listen.
Discussion questions
- Why did the researchers test the drug in mice?
- How could changes in blood flow affect brain scans?
- Have you seen a brain scan before? How did it seem to you?
Related articles
Needle-free spray delivers last-resort antibiotics
Researchers developed a needle-free spray-mist device to push last-resort antibiotics through the skin into infected tissue. The method aims to treat drug-resistant infections while reducing organ damage linked to intravenous delivery.
Affordable twice-yearly HIV injection lenacapavir to reach 120 countries
Lenacapavir, a twice-yearly HIV prevention injection, will be licensed for 120 low- and middle-income countries at US$40 a year. Rollout is expected from 2027 with funding support, but some countries and price transparency remain concerns.
Protein sensor lets MRI detect molecular activity
Researchers developed a genetically encoded protein sensor, called MAPPER, that makes molecular activity visible to MRI by changing water movement in cells. The modular system could let scientists image processes like cancer and inflammation continuously in animals.